RxDoctor Payments Data

Sergio Lozano

Physician Assistant · McAllen, TXNPI 1326464447

Payments from drug & device makers

$5,169in general payments, 2019–2025

Across 274 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$688
  • AstraZeneca$634
  • Lilly USA, LLC$633
  • AbbVie$627
  • Abbott$498
  • Amarin Pharma, Inc.$367
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,98496%
  • Education$1854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,169 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$26,071
LinzessLinaclotide31$19,226
MounjaroTirzepatide12$12,738
VascepaIcosapent Ethyl17$11,059
Icosapent Ethyl14$3,548
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,490
Ezetimibe21$1,407
Rosuvastatin Calcium92$1,113
Metoprolol Succinate58$1,030
Diclofenac Sodium20$800
Albuterol Sulfate HfaAlbuterol Sulfate27$789
Omeprazole54$777
Atorvastatin Calcium71$680
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst39$574
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide13$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$688$26,07113 claims
AbbVieLinzess$627$19,22631 claims
Lilly USA, LLCMounjaro$633$12,73812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in McAllen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →